Xcout Intel
CytoTronics, Inc.
CytoTronics is a biotechnology research company headquartered in Boston, Massachusetts, specializing in cell-based discovery and high-density electrode array technology.
Subscribe to see CytoTronics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CytoTronics, Inc. at a glance
CytoTronics, Inc. is a biotechnology company headquartered in United States. It has raised at least $23.3M across the 2 funding rounds on record. Its most recent funding round, Seed, raised $14M in September 2024. Xcout tracks 1 named person at CytoTronics, Inc., including Jeffrey Abbott (Chief Executive Officer).
CytoTronics, Inc. leadership
- Jeffrey AbbottChief Executive Officer
CytoTronics, Inc. funding rounds
At least $23.3M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $14M | 6 named | |
| Seed | $9.3M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
CytoTronics, Inc. competitors
A few of CytoTronics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Kytopen Corp. is a biotechnology company focused on cell therapy discovery, with facilities located in Cambridge, Massachusetts, and Louisville, Colorado, as well as an international expansion in Germany.
Organoid Therapeutics, Inc. is a biotechnology contract research organization (CRO) that provides human brain tissue models, neuronal phenotyping, drug screening, and machine learning-based analytical services. The company serves pharmaceutical, biotech, and academic researchers by conducting pre-clinical research and translational studies to evaluate drug efficacy, neurotoxicity, and neurological disease models.
Ginkgo Bioworks is a biotechnology research company headquartered in Boston, Massachusetts, that provides autonomous lab platforms for automated biological experiments.
Axol Bioscience is a leading provider of iPSC-derived cells and related services, supporting neuroscience, ophthalmology, and cardiotoxicity drug discovery with advanced human disease models.
StemoniX, Inc. was a for-profit biotechnology company with its headquarters located in Maple Grove, Minnesota. The firm developed innovative human cellular models and microfluidic technologies for drug discovery and toxicity testing.
DeepCyte Inc. is an AI-powered biotechnology and toxicology platform headquartered in Wilmington, Delaware. Established in 2025, the company develops advanced computational tools for toxicity assessment and life sciences research.
Get CytoTronics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about CytoTronics, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on CytoTronics, Inc. in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access